Montpellier-based Wefight is looking for a buyer

Time is of the essence for Wefight, the developer of Vik chatbots supporting cancer and chronic disease patients and their loved ones: on October 2, bankruptcy proceedings were imposed at the Montpellier Commercial Court. The start-up was founded in early 2017 and now has a month to find a buyer…

“We are doing everything in our power to achieve this”, president Benoît Brouard, co-founder in 2017 with Pierre Nectoux, said late last week. Wefight, which raised €10 million (from Digital Health Ventures, Impact Partners, Badge, Investir&+) in September 2021 to fund “very ambitious” international development, has built a foothold in Berlin and New York.

In 2023, a new collection was needed

But according to Benoît Brouard, a new fundraising was necessary in 2023 to support this development, an operation that could not be carried out. Wefight has launched a plan to significantly reduce costs “move from a trajectory of a hyper-growth structure to a profitable structure”.

The e-health start-up posted a turnover of just over 4.5 million euros for 2022, but accompanied by a loss of 3.5 million euros. Benoît Brouard argues with an economic model: “We have generated more than 10 million euros in cumulative turnover. We have about fifteen major clients.” To adapt to the new conditions, the start-up’s workforce, which had grown to around 70 employees, has now dropped to around forty, including around twenty at the head office in Montpellier and around twenty in Paris.

Around fifteen chatbots deployed

To help sick people manage day-to-day care, Wefight has already deployed about fifteen free chat apps, “Vik Companions”. These chatbots are linked to breast, prostate and lung cancer, but also depression, asthma, psoriasis, etc. According to Benoît Brouard, the activity is maintained. Note that the Montpellier start-up was the winner of the ninth wave of the I-Nov innovation competition under “France 2030”, announced in January 2023.

It received a grant of 1.117 million euros for the research project “IA Vik” with a cost of 2.5 million euros in the period 2022-2025. The challenge is to move from an informative solution to a predictive solution using machine learning to detect clinical symptoms or associations of relevant clinical symptoms and to improve the dematerialized monitoring of cancer patients by preventing risks of complications and relapses. .

Leave a Comment